Conserved programmed cell death patterns associate with subtype-specific therapeutic response across multiple cancer types
Journal of Clinical Investigation · 17.11.2026
DOI: 10.1172/jci203289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.11.2026. Verfasst von Zi-Wei Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Un…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, HE Science Foundation.
Abstract (Originalsprache)
BACKGROUND. Molecular subtyping may offer a promising path toward a unified framework for precision oncology. We sought to characterize the patterns of programmed cell death (PCD), a pivotal cellular process shaping both intrinsic tumor malignancy and the tumor microenvironment, to better understand tumor heterogeneity. METHODS. We performed integrative multi-cohort transcriptomic analyses encompassing four canonical PCD modes across multiple cancer types. We identified PCD subtypes using nonnegative matrix factorization (NMF), characterized their molecular features and clinical relevance, and developed a streamlined 20-gene classifier to facilitate subtype assignment. RESULTS. We identified five conserved PCD subtypes with distinct genomic alterations, cellular stresses, malignant traits, prognostic outcomes, and immune landscapes. In the immunotherapy setting, PCD subtypes were associated with distinct outcomes across multiple cancer types, with the pyroptosis-dominant (PCD-P) subtype showing the most favorable outcomes. The 20-gene classifier showed good discriminatory performance across independent cohorts. Finally, we proposed candidate subtype-specific therapeutic strategies. CONCLUSION. This study establishes a comprehensive framework for characterizing PCD patterns in cancer, laying the groundwork for biomarker discovery and rational therapeutic design that warrant future evaluation of efficacy and toxicity. FUNDING. National Key R&D Program of China; National Natural Science Foundation of China; Fundamental Research Funds for the Central Universities, Sun Yat-sen University; HE Science Foundation; Young Talents Program of Sun Yat-sen University Cancer Center; Academician Workstation of Jun Ma; Specific Research Fund of the Innovation Platform for Academicians of Hainan Province; Shenzhen Medical Research Fund; Guangdong Basic and Applied Basic Research Foundation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory o, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The Third Affiliated Hospital of Sun Yat-sen U…
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen…
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- HE Science Foundation
- Young Talents Program of Sun Yat-sen University Cancer Center
- Academician Workstation of Jun Ma
- Specific Research Fund of the Innovation Platform for Academicians of Hainan Province
- Shenzhen Medical Research Fund
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Huang, Z. W., Wang, Z. H., Liu, Y., Shen, J. Y., Wu, Y. L., Fang, Z. A., Wu, D. H., Cheng, Y. Z., Zhang, J. J., Zou, X., Ma, J., Lv, J., Wang, S., & Chen, Y. P. (2026). Conserved programmed cell death patterns associate with subtype-specific therapeutic response across multiple cancer types. Journal of Clinical Investigation. https://doi.org/10.1172/jci203289
Vancouver
Huang ZW, Wang ZH, Liu Y, Shen JY, Wu YL, Fang ZA, et al. Conserved programmed cell death patterns associate with subtype-specific therapeutic response across multiple cancer types. Journal of Clinical Investigation. 2026. doi:10.1172/jci203289
BibTeX
@article{Huang2026,
author = {Huang, Zi-Wei and Wang, Zi-Han and Liu, Yi and Shen, Jia-Yi and Wu, Yan-Ling and Fang, Zi-An and Wu, Dong-Hong and Cheng, Yi-Zhe and Zhang, Jing-Jing and Zou, Xiong and Ma, Jun and Lv, Jiawei and Wang, Shuang and Chen, Yu-Pei},
title = {Conserved programmed cell death patterns associate with subtype-specific therapeutic response across multiple cancer types},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci203289}
}
EUVIMED